Chhabra, Arpit
Ong, Leonard T
Kuk, Deborah
Ku, Geoffrey
Ilson, David
Janjigian, Yelena Y
Wu, Abraham
Schöder, Heiko
Goodman, Karyn A
Article History
Received: 1 July 2015
Revised: 8 October 2015
Accepted: 4 November 2015
First Online: 10 December 2015
Competing interests
: YYJ: disclosures include current consultancy with Eli Lilly as well as current grants received from Amgen, Eli Lilly, Boehringer Ingelheim and Bayer. In addition, receipt of past compensation for lectures from AXIS CME. AW: disclosures include past consultancy with Pfizer. DI: disclosures include ongoing consultancy with Amgen and Lilly. In addition, ongoing grants received from Bayer and Amgen as well as ongoing compensation for lectures from Roche. The remaining authors declare no conflict of interest.